F
Flow Neuroscience
Develops a new kind of depression treatment which combines an easy-to-use brain stimulation headset with a personalized mobile app
About Flow Neuroscience
Flow Neuroscience is a medical device company that has developed an at-home treatment for depression. The company's primary offering is a headset that uses transcranial direct current stimulation (tDCS) to target the dorsolateral prefrontal cortex, the area of the brain responsible for regulating mood. This headset is paired with a mobile application that provides a virtual therapy program. The treatment is designed for individuals diagnosed with major depressive disorder (MDD) and is available for purchase or rent directly from the company's website.
Read full description
The business model is direct-to-consumer, with a focus on providing a medication-free alternative for depression treatment. The company has received regulatory approval in Europe (CE mark) and the UK, and is seeking FDA approval in the United States. The treatment program is based on clinical evidence and research, with several studies supporting its efficacy in reducing depressive symptoms.
At a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Malmö kommun, Sweden
- Employees
- 41
- Open positions
- None listed
- Dealroom signal
- 73.9/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- BioTechnology, Medical Devices, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Neurology, Remote Monitoring
- Technology
- Deep Tech, Connected Device
- Business model
- Manufacturing, Marketplace & ecommerce, SaaS
- Client focus
- b2c
- Investment activity
- 1 company, latest Feb 2021
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SUPPORT PROGRAM✓Other financing | Feb 2026 | $0 | — | One Mind Accelerator | ↗ |
| SUPPORT PROGRAM✓Other financing | Jun 2023 | $0 | — | MedTech Innovator | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Flow Neuroscience is 160K monthly website visits, up 45.5% over the last three months. Flow Neuroscience's team declined 4.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
- DADaniel Andersson
SOSV
Series A7 investors entered at this stage
Khosla Ventures
Zühlke Ventures
SwissHealth Ventures
Global Brain Corporation
Schox Patent Group
Redstone
CSS Insurance
Other known investors10 additional known investors
EIT Health
Lund University
MedTech Innovator
One Mind Accelerator
Hax- JPJAZZ Venture Partners
Kirin Health Innovation Fund
Minc
naturalX Health Ventures
VentureLab by Lund University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Flow Neuroscience on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Flow Neuroscience’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.